Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia

Journal of Affective Disorders

Volumn 39, Issue 2, 1996, Pages 115-121

  Van Ameringen, Michael ^a,b   Mancini, Catherine ^a   Wilson, Carol ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Augmentation; Pharmacotherapy; Phobia; Social anxiety; Social phobia

Indexed keywords

BUSPIRONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFICACY; FATIGUE; FEMALE; HUMAN; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PHOBIA; PRIORITY JOURNAL;

EID: 0030575374     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-0327(96)00030-4     Document Type: Article

References (41)

1. Alessi, N. and Bos, T. (1991) Buspirone augmentation of fluoxetine in a depressed child with obsessive-compulsive disorder. Am. J. Psychiatry 148, 1605-1606.
2. Bakish, D. (1991) Fluoxetine potentiation by buspirone: three case histories. Can. J. Psychiatry 36, 749-50.
3. Beck, A.T., Ward, C.H., Mendolson, M., Mock, J. and Erbaugh, J. (1961) An inventory for measuring depression. Arch. Gen. Psychiatry 4, 561-571.
4. Black, B., Uhde, T. and Tancer, M. (1992) Fluoxetine for the treatment of social phobia. J. Clin. Psychopharmacol. 12, 293-295.
5. Bodkin, J.A. et al. (1989) Fluoxetine may antagonize the anxiolytic action of buspirone. J. Clin. Psychopharmacol. 9, 150.
6. Davidson, J.R.T., Potts, N.S., Richichi, E., Krishnan, R., Ford, S.M., Smith, R.D. and Wilson, W.H. (1993) Treatment of social phobia with clonazepam and placebo. J. Clin. Psychopharmacol. 13, 423-428.
7. Fabre, L.F. (1990) Buspironie in the management of major depression: a placebo-controlled comparison. J. Clin. Psychiatry 51 (Suppl. 9), 55-61.
8. Gammans, R.E., Mayol, R.F. and Labudde, J.A. (1986) Metabolism and disposition of buspirone. Am. J. Med. 80 (Suppl. 3B), 41-51.
9. Gelernter, C.S., Uhde, T.W., Cimbolic, P., Arnkoff, D.B., Vittone, B.J., Tancer, M.E. and Bartko, J.J. (1991) Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Arch. Gen. Psychiatry 48, 938-945.
10. Gorman, J.M., Liebowitz, M.R., Fyer, A.J., Campeas, R. and Klein, D.F. (1985) Treatment of social phobia with Atenolol. J. Clin. Psychopharmacol. 5, 298-301.
11. Grady, T.A., Pigott, T.A., L'Heureux, F., Hill, J.L., Bernstein, S.E. and Murphy, D.L. (1993) Double-blind study of adjuvant buspirone for fluoxetine treated patients with obsessive-compulsive disorder. Am. J. Psychiatry 150, 819-821.
12. Hartman, L.M. (1984) Cognitive components of anxiety. J. Clin. Psychol. 40, 137-139.
13. Humble, M., Fahlen, T., Koczkas, C. and Nilsson, H. (1992) Social phobia-efficacy of brofaromine versus placebo. Presented before 145 Annual Meeting of the American Psychiatric Association, Washington, DC, USA.
14. Jacobsen, F.M. (1991) Possible augmentation of antidepressant response by buspirone. J. Clin. Psychiatry 52, 217-220.
15. Jenike, M., Baer, L. and Buttolph, L. (1991) Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder. J. Clin. Psychiatry 52, 13-14.
16. Joffe, R. and Schuller, D.R. (1993) An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J. Clin. Psychiatry 54, 269-271.
17. Liebowitz, M.R., Gorman, J.M., Fyer, A.J., Campeas, R., Levin, A.P., Sandberg, D., Hollander, E., Papp, L. and Goetz, D. (1988) Pharmacotherapy of social phobia. An interim report of a placebo-controlled comparison of phenelzine and atenolol. J. Clin. Psychiatry 49, 252-257.
18. Liebowitz, M.R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., Fyer, A., Gorman, J., Papp, L., Davies, S., Gully, R. and Klein, D.F. (1992) Phenelzine vs atenolol in social phobia. A placebo-controlled comparison. Arch. Gen. Psychiatry 49, 290-300.
19. Lydiard, R.B., Laraia, M.T., Howell, E.F. and Ballenger, J.C. (1988) Alprazolam in the treatment of social phobia. J. Clin. Psychiatry 49, 17-19.
20. Marks, I.M. and Mathews, A.M. (1979) Brief standard self-rating for phobic patients. Behav. Res. Ther. 17, 267-270.
21. Metz, A. (1990) Ineraction between fluoxetine and buspirone. Can. J. Psychiatry 35, 722-723.
22. Munjack, D.J., Bruns, J., Baltazar, P.L., Brown, R., Leonard, M., Nagy, R., Koek, R., Crocker, B. and Schafer, S. (1991) A pilot study of buspirone in the treatment of social phobia. J. Anxiety Disord. 5, 87-98.
23. Price, L. (1990) Pharmacological Strategies in Refractory Depression. In: Tasman et al. (Eds.), American Psychiatric Press Review of Psychiatry. Vol. 9. American Psychiatric Press, Washington, DC, pp. 116-131.
24. Reich, J. and Yates, W. (1988) A pilot study of treatment of social phobia with alprazolam. Am. J. Psychiatry 145, 590-594.
25. Schneier, F.R., Chin, S.J., Hollander, E. and Liebowitz, M.R. (1992) Fluoxetine in social phobia. J. Clin. Psychopharmacol. 12, 62-64.
26. Schneier, F.R., Saoud, J.B., Campeas, R., Fallen, B.A., Hollander, E., Coplan, J. and Liebowitz, M. (1993) Buspirone in social phobia. J. Clin. Psychopharmacol. 13, 251-256.
27. Sheehan, D.V. (1983) The Sheehan Disability Scales. In: The Anxiety Disease. Charles Scribner and Sons, New York, NY, p. 151.
28. Spielberger, C.D., Grsuch, R.L. and Lushene, R.E. (1970) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press. Palo Alto, CA.
29. Spitzer, R.L., Williams, J.B.W., Gibbon, M. and First, M.B. (1988) Clinical interview for DSM-III-R patient version. Biometrics Research Department. York New State Psychiatric Institute, New York, NY.
30. Sternbach, H. (1990) Fluoxetine treatment of social phobia. J. Clin. Psychopharmacol. 10, 230-231.
31. Sternlicht, H.C. (1993) Obsessive-compulsive disorder, fluoxetine and buspirone. Am. J. Psychiatry 150, 526.
32. Tanquary, J., Masand, P. (1990) Paradoxical reaction to buspirone augmentation of fluoxetine. J. Clin. Psychopharmacol. 10 377.
33. Taylor, S., Woody, S., McLean, P.D. and Koch, W.J. (1996) Sensitivity of outcome measures for treatments of generalized social phobia. (unpublished manuscript)
34. Tyrer, P., Murphy, S. and Owen, R.T. (1985) The risk of pharmacological dependence with buspirone. Br. J. Clin. Pract. 39 (Suppl. 38), 91-93.
35. Van Ameringen, M., Mancini, C. and Streiner, D. (1993) Fluoxetine efficacy in social phobia. J. Clin. Psychiatry 54, 27-32.
36. Van Ameringen, M., Mancini, C. and Streiner, D. (1994) Sertraline in social phobia. J. Affect. Disord. 31, 141-145.
37. Van Vliet, L.M., Den Boer, J.A. and Westenberg, H.G.M. (1992) Psychopharmacological treatment of social phobia: clinical and biochemical effects of biofaromine a selective MAO-A inhibitor. Eur. Neuropsychopharmacol. 2, 21-29.
38. Van Vliet, L.M., Den Boer, J. and Westenberg, H.G.M. (1994) Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine. Psychopharmacology 115, 128-134.
39. Versiani, M., Mundim, F.D., Nardi, A.E. and Liebowitz, M.R. (1988) Tranylcypromine in social phobia. J. Clin. Psychopharmacol. 8, 279-283.
40. Versiani, M., Nardi, E., Mundim, F.D., Alves, A.B., Liebowitz, M.R. and Amrein, R. (1992) Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. Br. J. Psychiatry 161, 353-360.
41. Watson, D. and Friend, R. (1969) Measurement of social evaluative anxiety. J. Consult. Clin. Psychol. 33, 448-457.